Exploration of the Hepatoprotective Effect and Mechanism of Swertia mussotii Franch in an Acute Liver Injury Rat Model

Author(s): Haixia Yun, Xianglan Duan, Wendou Xiong, Yiwei Ding, Xinyu Wu, Junhua Kang, Xiaoyan Pu, Yingzhong Yang, Zhi Chen*

Journal Name: Combinatorial Chemistry & High Throughput Screening
Accelerated Technologies for Biotechnology, Bioassays, Medicinal Chemistry and Natural Products Research

Volume 22 , Issue 9 , 2019

Become EABM
Become Reviewer


Background and Objective: Swertia mussotii Franch, also known as “Zangyinchen”, is one of a Tibetan traditional herb used for treatment of liver diseases over thousands of years at Qinghai-Tibet Plateau, has been confirmed to be hepatoprotective. However, the underlying mechanism is largely unknown.

Materials and Methods: In this study, we evaluated the effect of S. mussotii treatment in a carbon tetrachloride-induced acute liver injury rat model by examining the serum alanine aminotransferase, aspartate aminotransferase, total bilirubin levels and performing histological observations of the liver tissues. Meanwhile, the metabolomics analysis was used to explore the molecular mechanism of S. mussotii treatment by high performance liquid chromatography tandem mass spectrometry.

Results: The results showed that S. mussotii treatment could effectively improve the serum alanine aminotransferase, aspartate aminotransferase, total bilirubin in acute liver injury rat model. Histological observation showed that S. mussotii treatment could effectively alleviate liver injury. Moreover, the metabolomics analysis showed that S. mussotii treatment could normalize the levels of many fatty acid metabolism related metabolites. And the results of pathway analysis showed that these metabolites significantly enriched in fatty acid biosynthesis pathway (myristic acid, dodecanoic acid and capric acid) and linoleic acid metabolism pathway (13-OxoODE).

Conclusion: The results indicated that S. mussotii treatment could significantly improve acute liver injury through affecting the pathways related to lipid metabolism.

Keywords: Acute liver injury, Swertia mussotii Franch, metabolomics, fatty acid biosynthesis, serum examination, herb.

Song, P.; Xia, J.; Rezeng, C.; Tong, L.; Tang, W. Traditional, complementary, and alternative medicine: Focusing on research into traditional Tibetan medicine in China. Biosci. Trends, 2016, 10(3), 163-170.
[http://dx.doi.org/10.5582/bst.2016.01105] [PMID: 27301588]
Schwabl, H.; Vennos, C. From medical tradition to traditional medicine: A Tibetan formula in the European framework. J. Ethnopharmacol., 2015, 167, 108-114.
[http://dx.doi.org/10.1016/j.jep.2014.10.033] [PMID: 25446636]
Bauer-Wu, S.; Lhundup, T.; Tidwell, T.; Lhadon, T.; Ozawa-de Silva, C.; Dolma, J.; Dorjee, P.; Neshar, D.R.; Sangmo, R.; Yeshi, T. Tibetan medicine for cancer: An overview and review of case studies. Integr. Cancer Ther., 2014, 13(6), 502-512.
[http://dx.doi.org/10.1177/1534735414549624] [PMID: 25209591]
Jing, L.; Su, S.; Zhang, D.; Li, Z.; Lu, D.; Ge, R. Srolo Bzhtang, a traditional Tibetan medicine formula, inhibits cigarette smoke induced airway inflammation and muc5ac hypersecretion via suppressing IL-13/STAT6 signaling pathway in rats. J. Ethnopharmacol., 2019, 235, 424-434.
[http://dx.doi.org/10.1016/j.jep.2019.02.006] [PMID: 30731182]
Li, Q.; Li, H.J.; Xu, T.; Du, H.; Huan , Gang C.L.; Fan, G.; Zhang, Y. Natural medicines used in the traditional tibetan medical system for the treatment of liver diseases. Front. Pharmacol., 2018, 9, 29.
[http://dx.doi.org/10.3389/fphar.2018.00029] [PMID: 29441019]
Liu, Y.; Wang, Y.; Guo, F.; Zhan, L.; Mohr, T.; Cheng, P.; Huo, N.; Gu, R.; Pei, D.; Sun, J.; Tang, L.; Long, C.; Huang, L.; Gu, Y.Q. Deep sequencing and transcriptome analyses to identify genes involved in secoiridoid biosynthesis in the Tibetan medicinal plant Swertia mussotii. Sci. Rep., 2017, 7, 43108.
[http://dx.doi.org/10.1038/srep43108] [PMID: 28225035]
Fan, G.; Luo, W.Z.; Luo, S.H.; Li, Y.; Meng, X.L.; Zhou, X.D.; Zhang, Y. Metabolic discrimination of Swertia mussotii and Swertia chirayita known as “Zangyinchen” in traditional Tibetan medicine by (1)H NMR-based metabolomics. J. Pharm. Biomed. Anal., 2014, 98, 364-370.
[http://dx.doi.org/10.1016/j.jpba.2014.06.014] [PMID: 24992216]
Cao, Y.; Wang, Y.; Ye, J. Differentiation of Swertia mussotii Franch from artemisiae capillaris herba by capillary electrophoresis with electrochemical detection. J. Pharm. Biomed. Anal., 2005, 39(1-2), 60-65.
[http://dx.doi.org/10.1016/j.jpba.2005.03.006] [PMID: 16085134]
Li, H.; Cao, W.; Lu, M.; Wu, C.; Wang, X.; Niu, L. Urinary and serum metabolomics analyses uncover that total glucosides of paeony protect liver against acute injury potentially via reprogramming of multiple metabolic pathways. Evid. Based Complement. Alternat. Med., 2017, 20179038260
[http://dx.doi.org/10.1155/2017/9038260] [PMID: 29375644]
Galligani, L.; Lonati-Galligani, M.; Fuller, G.C. Collagen synthesis in explant cultures of normal and CCl4-treated mouse liver. Toxicol. Appl. Pharmacol., 1979, 48(1 Pt 1), 131-137.
[http://dx.doi.org/10.1016/S0041-008X(79)80015-0] [PMID: 222011]
Chong, J.; Soufan, O.; Li, C.; Caraus, I.; Li, S.; Bourque, G.; Wishart, D.S.; Xia, J. MetaboAnalyst 4.0: Towards more transparent and integrative metabolomics analysis. Nucleic Acids Res., 2018, 46(W1), W486-W494.
[http://dx.doi.org/10.1093/nar/gky310] [PMID: 29762782]
Zhao, J.; Hu, H.; Wan, Y.; Zhang, Y.; Zheng, L.; Hong, Z. Pien Tze Huang Gan Bao ameliorates carbon tetrachloride-induced hepatic injury, oxidative stress and inflammation in rats. Exp. Ther. Med., 2017, 13(5), 1820-1826.
[http://dx.doi.org/10.3892/etm.2017.4174] [PMID: 28565773]
Kuna, L.; Bozic, I.; Kizivat, T.; Bojanic, K.; Mrso, M.; Kralj, E.; Smolic, R.; Wu, G.Y.; Smolic, M. Models of drug induced liver injury (DILI) - Current issues and future perspectives. Curr. Drug Metab., 2018, 19(10), 830-838.
[http://dx.doi.org/10.2174/1389200219666180523095355] [PMID: 29788883]
Chen, Q.; Zheng, J.; Shao, Y.; Ai, N.; Wu, L.; Liu, Y.; Lu, X.; Fan, X. Network-based assessment on chemical-induced cholestatic liver injury. Curr. Top. Med. Chem., 2016, 16(30), 3668-3677.
[http://dx.doi.org/10.2174/1568026616666160721095647] [PMID: 27334198]
Wang, P.; Zhang, Y.; An, Y.; Xu, K.; Xu, X.; Fu, C.; Lin, J.; Xu, S.; Li, Q.; Lei, H. Protection of a new heptapeptide from Carapax trionycis against carbon tetrachloride-induced acute liver injury in mice. Chem. Pharm. Bull. (Tokyo), 2013, 61(11), 1130-1135.
[http://dx.doi.org/10.1248/cpb.c13-00442] [PMID: 24189300]
Hong, M.; Li, S.; Wang, N.; Tan, H.Y.; Cheung, F.; Feng, Y. A Biomedical Investigation of the Hepatoprotective Effect of Radix salviae miltiorrhizae and Network Pharmacology-Based Prediction of the Active Compounds and Molecular Targets. Int. J. Mol. Sci., 2017, 18(3)E620
[http://dx.doi.org/10.3390/ijms18030620] [PMID: 28335383]
Chen, K.L.; Bi, K.S.; Han, F.; Zhu, H.Y.; Zhang, X.S.; Mao, X.J.; Yin, R. Evaluation of the protective effect of Zhi-Zi-da-Huang decoction on acute liver injury with cholestasis induced by α-naphthylisothiocyanate in rats. J. Ethnopharmacol., 2015, 172, 402-409.
[http://dx.doi.org/10.1016/j.jep.2015.06.043] [PMID: 26163196]
Hong, M.; Li, S.; Tan, H.Y.; Wang, N.; Tsao, S.W.; Feng, Y. Current status of herbal medicines in chronic liver disease therapy: The biological effects, molecular targets and future prospects. Int. J. Mol. Sci., 2015, 16(12), 28705-28745.
[http://dx.doi.org/10.3390/ijms161226126] [PMID: 26633388]
Zhang, Y.; Liu, T.; Chen, L.; Yang, J.; Yin, J.; Zhang, Y.; Yun, Z.; Xu, H.; Ning, L.; Guo, F.; Jiang, Y.; Lin, H.; Wang, D.; Huang, Y.; Huang, J. RIscoper: A tool for RNA-RNA interaction extraction from the literature. Bioinformatics, 2019, 35(17), 3199-3202.
[http://dx.doi.org/10.1093/bioinformatics/btz044] [PMID: 30668649]
Yi, Y.; Zhao, Y.; Li, C.; Zhang, L.; Huang, H.; Li, Y.; Liu, L.; Hou, P.; Cui, T.; Tan, P.; Hu, Y.; Zhang, T.; Huang, Y.; Li, X.; Yu, J.; Wang, D. RAID v2.0: An updated resource of RNA-associated interactions across organisms. Nucleic Acids Res., 2017, 45(D1), D115-D118.
[http://dx.doi.org/10.1093/nar/gkw1052] [PMID: 27899615]
Zhang, L.; Cheng, Y.; Du, X.; Chen, S.; Feng, X.; Gao, Y.; Li, S.; Liu, L.; Yang, M.; Chen, L.; Peng, Z.; Yang, Y.; Luo, W.; Wang, R.; Chen, W.; Chai, J. Swertianlarin, an herbal agent derived from Swertia mussotii Franch, attenuates liver injury, inflammation, and cholestasis in common bile duct-ligated rats. Evid. Based Complement. Alternat. Med., 2015, 2015948376
[http://dx.doi.org/10.1155/2015/948376] [PMID: 26273316]
Feng, X.C.; Du, X.; Chen, S.; Yue, D.; Cheng, Y.; Zhang, L.; Gao, Y.; Li, S.; Chen, L.; Peng, Z.; Yang, Y.; Luo, W.; Wang, R.; Chen, W.; Chai, J. Swertianlarin, isolated from Swertia mussotii Franch, increases detoxification enzymes and efflux transporters expression in rats. Int. J. Clin. Exp. Pathol., 2015, 8(1), 184-195.
[PMID: 25755705]
Wang, H.; Yuan, X.; Huang, H.; Zhang, B.; Cao, C.; Zhao, H.P. Chemical constituents from Swertia mussotii Franch. (Gentianaceae). Nat. Prod. Res., 2017, 31(14), 1704-1708.
[http://dx.doi.org/10.1080/14786419.2017.1286480] [PMID: 28278647]
Canbay, A.; Bechmann, L.; Gerken, G. Lipid metabolism in the liver. Z. Gastroenterol., 2007, 45(1), 35-41.
[http://dx.doi.org/10.1055/s-2006-927368] [PMID: 17236119]
Sozio, M.S.; Liangpunsakul, S.; Crabb, D. The role of lipid metabolism in the pathogenesis of alcoholic and nonalcoholic hepatic steatosis. Semin. Liver Dis., 2010, 30(4), 378-390.
[http://dx.doi.org/10.1055/s-0030-1267538] [PMID: 20960377]
Chen, Y.S.; Chen, Q.Z.; Wang, Z.J.; Hua, C. Anti-inflammatory and hepatoprotective effects of ganoderma lucidum polysaccharides against carbon tetrachloride-induced liver injury in kunming mice. Pharmacology, 2019, 103(3-4), 143-150.
[http://dx.doi.org/10.1159/000493896] [PMID: 30673679]
Leclerc, D.; Christensen, K.E.; Cauvi, O.; Yang, E.; Fournelle, F.; Bahous, R.H.; Malysheva, O.V.; Deng, L.; Wu, Q.; Zhou, Z.; Gao, Z.H.; Chaurand, P.; Caudill, M.A.; Rozen, R. Mild methylenetetrahydrofolate reductase deficiency alters inflammatory and lipid pathways in liver. Mol. Nutr. Food Res., 2019, 63(3)e1801001
[http://dx.doi.org/10.1002/mnfr.201801001] [PMID: 30408316]
Wang, M.; Ma, L.J.; Yang, Y.; Xiao, Z.; Wan, J.B. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review. Crit. Rev. Food Sci. Nutr, 2018, 59(su[1), S116-S129.
[PMID: 30580553]
Karimi-Sales, E.; Ebrahimi-Kalan, A.; Alipour, M.R. Preventive effect of trans-chalcone on non-alcoholic steatohepatitis: Improvement of hepatic lipid metabolism. Biomed. Pharmacother., 2019, 109, 1306-1312.
[http://dx.doi.org/10.1016/j.biopha.2018.10.196] [PMID: 30551380]
Bellassoued, K.; Ghrab, F.; Hamed, H.; Kallel, R.; van Pelt, J.; Lahyani, A.; Ayadi, F.M.; El Feki, A. Protective effect of essential oil of Cinnamomum verum bark on hepatic and renal toxicity induced by carbon tetrachloride in rats. Appl. Physiol. Nutr. Metab., 2019, 44(6), 606-618.
[http://dx.doi.org/10.1139/apnm-2018-0246] [PMID: 30994004]
Cui, T.; Zhang, L.; Huang, Y.; Yi, Y.; Tan, P.; Zhao, Y.; Hu, Y.; Xu, L.; Li, E.; Wang, D. MNDR v2.0: An updated resource of ncRNA-disease associations in mammals. Nucleic Acids Res., 2018, 46(D1), D371-D374.
[http://dx.doi.org/10.1093/nar/gkx1025] [PMID: 29106639]

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2019
Page: [649 - 656]
Pages: 8
DOI: 10.2174/1386207322666191106105725
Price: $65

Article Metrics

PDF: 23